Header Logo

Connection

Maria Stegantseva to Immunoglobulins, Intravenous

Back to Details
This is a "connection" page, showing publications Maria Stegantseva has written about Immunoglobulins, Intravenous.
Maria Stegantseva
Connection Strength
0.037
Immunoglobulins, Intravenous
  1. Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections. Clin Immunol. 2019 08; 205:1-5.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.